Søgeresultater - Martin Lagging
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
10 RIBAVIRIN CONCENTRATION AT WEEK FOUR IS AN INDEPENDEND PREDICTOR FOR SUSTAINED VIROLOGICAL RESPONSE AFTER TREATMENT OF HEPATITIS C GENOTYPE 2/3 (NORDYNAMIC TRIAL) af Peer Brehm Christensen, Åsa Alsiö, Mads Rauning Buhl, Martti Färkkilâ, K. Mørch, Per Sangfelt, Martin Lagging, Gunnar Norkrans, C. Pedersen
Udgivet 2008Artigo -
9
-
10
Interleukin 28B Gene Variation at rs12979860 Determines Early Viral Kinetics During Treatment in Patients Carrying Genotypes 2 or 3 of Hepatitis C Virus af Magnus Lindh, Martin Lagging, Martti Färkkilâ, Nina Langeland, Kristine Mørch, Staffan Nilsson, Gunnar Norkrans, Court Pedersen, Mads Rauning Buhl, Johan Westin, Kristoffer Hellstrand
Udgivet 2011Artigo -
11
Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C af Peter Derek Christian Leutscher, Martin Lagging, Mads Rauning Buhl, Court Pedersen, Gunnar Norkrans, Nina Langeland, Kristine Mørch, Martti Färkkilâ, Simon Hjerrild, Kristoffer Hellstrand, Per Bech
Udgivet 2010Artigo -
12
Randomized comparison of 12 or 24 weeks of peginterferon α-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection af Martin Lagging, Nina Langeland, Court Pedersen, Martti Färkkilâ, Mads Rauning Buhl, Kristine Mφrch, Amar P. Dhillon, Åsa Alsiö, Kristoffer Hellstrand, Johan Westin, Gunnar Norkrans
Udgivet 2008Artigo -
13
Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepat... af Galia Askarieh, Åsa Alsiö, Paolo Pugnale, Francesco Negro, Carlo Ferrari, Avidan U. Neumann, Jean‐Michel Pawlotsky, Solko W. Schalm, Stefan Zeuzem, Gunnar Norkrans, Johan Westin, Jonas Söderholm, Kristoffer Hellstrand, Martin Lagging
Udgivet 2009Artigo -
14
Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19 af Fredy Saguti, Ellen Magnil, Lucica Enache, Marianela Patzi Churqui, Anette Johansson, D. Lumley, Fredrik Davidsson, Leif Dotevall, Ann E. Mattsson, Edward Trybala, Martin Lagging, Magnus Lindh, Magnus Gisslén, Thomas Brezicka, Kristina Nyström, Heléne Norder
Udgivet 2020Artigo -
15
IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C af G. Fattovich, Loredana Covolo, Stéphanie Bibert, Galia Askarieh, Martin Lagging, Sophie Clément, Giovanni Malerba, M. Pasino, M. Guido, Massimo Puoti, G.B. Gaeta, Teresa Santantonio, G. Raimondo, Raffaele Bruno, Pierre‐Yves Bochud, Francesco Donato, Francesco Negro
Udgivet 2011Artigo -
16
Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms af Martin Lagging, Galia Askarieh, Francesco Negro, Stéphanie Bibert, Jonas Söderholm, Johan Westin, Magnus Lindh, Ana I. Romero, Gabriele Missale, Carlo Ferrari, Avidan U. Neumann, Jean‐Michel Pawlotsky, Bart L. Haagmans, Stefan Zeuzem, Pierre‐Yves Bochud, Kristoffer Hellstrand
Udgivet 2011Artigo -
17
Interferon (IFN)–γ–Inducible Protein–10: Association with Histological Results, Viral Kinetics, and Outcome during Treatment with Pegylated IFN‐α2a and Ribavirin for Chronic Hepati... af Ana I. Romero, Martin Lagging, Johan Westin, Amar P. Dhillon, Lynn B. Dustin, Jean‐Michel Pawlotsky, Avidan U. Neumann, Carlo Ferrari, Gabriele Missale, Bart L. Haagmans, Solko W. Schalm, Stefan Zeuzem, Francesco Negro, Elke Verheij‐Hart, Kristoffer Hellstrand
Udgivet 2006Artigo -
18
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection af Martin Lagging, Ana I. Romero, Johan Westin, Gunnar Norkrans, Amar P. Dhillon, Jean‐Michel Pawlotsky, Stefan Zeuzem, Michael Wagner, Francesco Negro, Solko W. Schalm, Bart L. Haagmans, Carlo Ferrari, Gabriele Missale, Avidan U. Neumann, Elke Verheij‐Hart, Kristoffer Hellstrand
Udgivet 2006Artigo -
19
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries af Homie Razavi, Marı́a Buti, Norah A. Terrault, Stefan Zeuzem, Cihan Yurdaydın, Junko Tanaka, Alessio Aghemo, Ulus Salih Akarca, N. Masri, Abduljaleel Alalwan, Soo Aleman, Abdullah S Alghamdi, Saad Alghamdi, Waleed K. Al‐Hamoudi, Abdulrahman Aljumah, Ibrahim Altraif, Tarik Asselah, Ziv Ben‐Ari, Thomas Berg, Mia J. Biondi, Sarah Blach, Wornei Silva Miranda Braga, Carlos Eduardo Brandão‐Mello, Maurizia Rossana Brunetto, Joaquín Cabezas, Hugo Cheinquer, Pei‐Jer Chen, Myeong-Eun Cheon, Wan‐Long Chuang, Carla S. Coffin, Nicola Coppola, Antonio Craxı̀, Javier Crespo, Victor de Lédinghen, Ann‐Sofi Duberg, Ohad Etzion, Maria Lúcia Gomes Ferraz, Paulo Roberto Abrão Ferreira, Xavier Forns, Graham R. Foster, Giovanni Battista Gaeta, Ivane Gamkrelidze, Javier García‐Samaniego, Liliana Gheorghe, Pierre M. Gholam, Robert G. Gish, Jeffrey S. Glenn, Julian Hercun, Yao‐Chun Hsu, Ching‐Chih Hu, Jee‐Fu Huang, Naveed Z. Janjua, Jidong Jia, Martin Kåberg, Kelly Kaita, Habiba Kamal, Jia‐Horng Kao, Loreta A. Kondili, Martin Lagging, Pablo Lázaro, Jeffrey V. Lazarus, Mei‐Hsuan Lee, Young‐Suk Lim, Paul J. Marotta, María Cristina Navas, Marcelo Contardo Moscoso Naveira, Mauricio Orrego, Carla Osiowy, Calvin Q. Pan, Mário G. Pessôa, Giovanni Raimondo, Alnoor Ramji, Devin Razavi‐Shearer, Kathryn Razavi‐Shearer, Cielo Ríos, Manuel Rodríguez, William Rosenberg, Dominique Roulot, Stephen Ryder, Rifaat Safadi, Faisal M. Sanai, Teresa Santantonio, Christoph Sarrazin, Daniel Shouval, Frank Tacke, Tammo Lambert Tergast, Juan Miguel Villalobos-Salcedo, Alexis Voeller, Hwai‐I Yang, Ming‐Lung Yu, Eli Zuckerman
Udgivet 2023Artigo -
20
The case for simplifying and using absolute targets for viral hepatitis elimination goals af Graham R. Foster, James Fung, Javier García‐Samaniego, Robert G. Gish, Fernando Lopes Gonçales, Waldemar Halota, Waseem Hamoudi, Mohamed Hassany, Angelos Hatzakis, Susan M. Hay, Sayed Himatt, I M Hoepelman, Yao‐Chun Hsu, Yee Tak Hui, Béla Hunyady, Ira M. Jacobson, Naveed Z. Janjua, Harry L.A. Janssen, Peter Jarčuška, Kenneth Kabagambe, Tatsuya Kanto, Jia‐Horng Kao, Sabahattin Kaymakoğlu, David Kershenobich, Faryal Khamis, Dong Joon Kim, Do Young Kim, Loreta A. Kondili, Shyamasundaran Kottilil, Anna Kramvis, Marcelo Kugelmas, Masayuki Kurosaki, Karine Lacombe, Martin Lagging, Wai-Cheung Lao, Daniel Lavanchy, Jeffrey V. Lazarus, Alice Lee, Samual S Lee, Miriam Levy, Valentina Liakina, Young‐Suk Lim, Shuang Liu, Willis C. Maddrey, Reza Malekzadeh, Rui Tato Marinho, Poonam Mathur, Mojca Matičič, Maria Cássia Mendes Corrêa, Jorge Mera, Shahin Merat, Sherif Mogawer, Rosmawati Mohamed, Beat Muellhaupt, David Handojo Muljono, Ibrahim Mostafa, Mendez Sanchez Nahum, Arif Nawaz, Francesco Negro, Michael Ninburg, Qing Ning, Boatemaa Ntiri- Reid, Pagbajabyn Nymadawa, A. Oevrehus, Necati Örmecı, Mauricio Orrego, Alaa Osman, Tsendsuren Oyunsuren, Calvin Q. Pan, Vassiliki Papaevangelou, George Papatheodoridis, Stephanie Popping, Papu Prasad, Rittoo Prithiviputh, Huma Qureshi, Alnoor Ramji, Kathryn Razavi‐Shearer, K. Rajender Reddy, William Remak, Clemens Richter, Ezequiel Ridruejo, Geert Robaeys, Stuart Roberts, Lewis R. Roberts, Françoise Roudot‐Thoraval, Sammy Saab, Sanaa Said, Amjad Salamat, Faisal M. Sanai, J.F. Sánchez-Ávila, Eugene R. Schiff, Raymond F. Schinazi, Giada Sebastiani, Carole Seguin‐Devaux, R. P. Shanmugam, Ala I. Sharara, Sonjelle Shilton, Daniel Shouval, William Sievert, Marieta Simonova
Udgivet 2020Artigo
Søgeredskaber:
Relaterede emner
Virus
Medicine
Virology
Biology
Gene
Hepatitis C virus
Internal medicine
Genotype
Gastroenterology
Immunology
Ribavirin
Biochemistry
Hepatitis C
Genetics
Viral load
Hepacivirus
Antibody
Chronic hepatitis
Cirrhosis
Coronavirus disease 2019 (COVID-19)
Disease
HBsAg
Hepatitis B
Hepatitis B virus
Hepatitis D
Hepatitis D virus
Hepatocellular carcinoma
Infectious disease (medical specialty)
Interferon
Molecular biology